bpc-157 human clinical trials randomized double blind The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Is BPC-157 safe for use
Description
[DOI] [PubMed] [Google Scholar] Vitaic S, Stupnisek M, Drmic D, et al
In some people, these patches can appear all over the body
A standard cycle runs 12 weeks active, followed by 48 weeks off or 23 doses per week for maintenance
Some patients continue with weekly injections for 6 months or longer, then transition to biweekly or monthly maintenance
The peptide was specifically designed to avoid the glucose dysregulation associated with full-length growth hormone
